{"id":26453,"date":"2023-04-10T15:17:16","date_gmt":"2023-04-10T18:17:16","guid":{"rendered":"https:\/\/mindthegraph.com\/blog\/the-last-of-us-science-copy\/"},"modified":"2023-04-25T08:31:20","modified_gmt":"2023-04-25T11:31:20","slug":"new-treatment-for-alzheimers","status":"publish","type":"post","link":"https:\/\/mindthegraph.com\/blog\/lt\/naujas-gydyba-alzheimeriui-gydyti\/","title":{"rendered":"Kas yra lekanemabas - naujas Alzheimerio ligos gydymo b\u016bdas?"},"content":{"rendered":"<p>Alzheimerio liga ir kitos demencijos <a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.937486\/full\">sergamumas ir paplitimas padid\u0117jo 147,95% ir 160,84%<\/a>atitinkamai 1990-2019 m. Tai rodo, kaip pla\u010diai paplitusi Alzheimerio liga, kuri\u0105 apsunkina tai, kad n\u0117ra vaist\u0173 nuo jos.&nbsp;<\/p>\n\n\n\n<p>Pacientai ir slaugytojai jau seniai ie\u0161ko gydymo b\u016bd\u0173, ir kiekvienas naujas tyrimas suteikia jiems naujos vilties.<\/p>\n\n\n\n<p>Japonijos farmacijos bendrov\u0117 \"Eisai\" atrado vien\u0105 konkret\u0173 vaist\u0105, nauj\u0105 Alzheimerio ligos gydymo b\u016bd\u0105, kuris pagerino Alzheimerio liga sergan\u010di\u0173 pacient\u0173 pa\u017eintines funkcijas, kaip skelbiama \u017eurnale \"Eisai\". <a href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2212948\">\"New England Journal of Medicine\".<\/a><\/p>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" loading=\"lazy\" width=\"1024\" height=\"558\" src=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog3-1024x558.jpg\" alt=\"\" class=\"wp-image-27497\" srcset=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog3-1024x558.jpg 1024w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog3-300x163.jpg 300w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog3-768x419.jpg 768w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog3-18x10.jpg 18w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog3-100x54.jpg 100w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog3.jpg 1123w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\"><em>Iliustracijas galima rasti <strong><a href=\"https:\/\/mindthegraph.com\/app\/illustrations\" target=\"_blank\" rel=\"noreferrer noopener\">Mind the Graph<\/a><\/strong><\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><a href=\"https:\/\/newsnetwork.mayoclinic.org\/n7-mcnn\/7bcc9724adf7b803\/uploads\/2016\/03\/healthy-brain-and-alzheimers-brain-16x9.jpg\"><\/a>\u0160iame \"Mind The Graph\" straipsnyje supa\u017eindinama su \u0161iuo naujovi\u0161ku gydymu ir paai\u0161kinama, kaip jis gali pagerinti pacient\u0173, sergan\u010di\u0173 Alzheimerio liga, gydymo trajektorij\u0105.<\/p>\n\n\n\n<h2>Viskas, k\u0105 reikia \u017einoti apie nauj\u0105 Alzheimerio ligos gydymo b\u016bd\u0105<\/h2>\n\n\n\n<p>\u0160is naujas Alzheimerio ligos gydymo b\u016bdas - tai 18 m\u0117nesi\u0173 trukusio 3 faz\u0117s tyrimo, kuriame dalyvavo ankstyva Alzheimerio liga sergantys 50-90 met\u0173 \u017emon\u0117s, metu atrastas vaistas lekanemabas. Kad gal\u0117t\u0173 dalyvauti eksperimente, \u0161ie asmenys turi tur\u0117ti vidutinio sunkumo pa\u017einimo funkcij\u0173 sutrikim\u0105 arba lengv\u0105 Alzheimerio ligos sukelt\u0105 demencij\u0105 ir amiloido plok\u0161teli\u0173 po\u017eymi\u0173 smegenyse.<\/p>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" loading=\"lazy\" width=\"1024\" height=\"558\" src=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog1-1024x558.jpg\" alt=\"\" class=\"wp-image-27499\" srcset=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog1-1024x558.jpg 1024w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog1-300x163.jpg 300w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog1-768x419.jpg 768w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog1-18x10.jpg 18w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog1-100x54.jpg 100w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog1.jpg 1123w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\"><em>Iliustracijas galima rasti <strong><a href=\"https:\/\/mindthegraph.com\/app\/illustrations\" target=\"_blank\" rel=\"noreferrer noopener\">Mind the Graph<\/a><\/strong><\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><a href=\"https:\/\/www.brightfocus.org\/sites\/default\/files\/2022-04\/normal_vs_alzheimers_brain.jpeg\"><\/a>\u0160iame eksperimente pacientams \u012f ven\u0105 bus leid\u017eiamas lekanemabas arba placebas. Poky\u010diai buvo matuojami po 18 m\u0117nesi\u0173. Po \u0161io laikotarpio ankstyvosios Alzheimerio stadijos Alzheimerio liga sergantiems pacientams, vartojusiems lekanemab\u0105, pasirei\u0161k\u0117 <strong>27% ma\u017eiau kognityvini\u0173 sutrikim\u0173<\/strong> nei tie, kurie gavo placebo. Tai atitinka 0,45 balo pagal 18 bal\u0173 CDR-SB.<\/p>\n\n\n\n<p>Svarbiausias Alzheimerio ligos tyr\u0117j\u0173 tikslas buvo rasti s\u0117kming\u0105 gydymo b\u016bd\u0105, kuris pad\u0117t\u0173 kovoti su pagrindine ligos prie\u017eastimi - smegenyse esan\u010diomis amiloido plok\u0161tel\u0117mis - baltymu, kuris ardo neuronus ir kitas l\u0105steles. \u0160is baltymas susidaro skylant didesniam baltymui, vadinamam amiloido pirmtaku.<\/p>\n\n\n\n<p>Iki \u0161iol rasti nauj\u0105 Alzheimerio ligos gydymo b\u016bd\u0105 ir vaistus, galin\u010dius blokuoti amiloido plok\u0161teles ir kartu palengvinti ligos simptomus, buvo beveik pralaim\u0117tas karas. Vis d\u0117lto lekanemabas buvo pirmasis vaistas, kuriam tai pavyko padaryti.&nbsp;<\/p>\n\n\n\n<p>Anks\u010diau buvo atlikta daug kit\u0173 pana\u0161i\u0173 \u012f \u0161\u012f tyrim\u0173, ta\u010diau pana\u0161i\u0173 rezultat\u0173 nebuvo gauta. Pavyzd\u017eiui, adukanumabas, dar \u017einomas kaip Aduhelm, yra vaistas, kuris tapo prieinamas 2021 m. Pana\u0161iai kaip ir Lecanemabo atveju, Aducanumab\u0105 gavusiems asmenims pager\u0117jo kognityvini\u0173 test\u0173 rezultatai, palyginti su tais, kurie vartojo placeb\u0105. Adukanumabo poveikis buvo atskleistas ankstesniame 1 faz\u0117s tyrime, kuriame dalyvavo ma\u017eesnis pacient\u0173 skai\u010dius ir kuriuo buvo siekiama i\u0161tirti gydymo saugum\u0105, o ne veiksmingum\u0105.&nbsp;<\/p>\n\n\n\n<p>Kadangi vaisto privalumai nebuvo patikimai ir nuosekliai pakartoti 3 faz\u0117s tyrimuose, Medicinos ir medicinos paslaug\u0173 centrai nusprend\u0117 nemok\u0117ti didel\u0117s vaisto kainos, kuri kainuoja $56 000 per metus, o gydymo veiksmingumui nustatyti reikia atlikti daugiau tyrim\u0173.&nbsp;<\/p>\n\n\n\n<p>Nors abu vaistai atrodo gana pana\u0161\u016bs, b\u016btina pabr\u0117\u017eti, kad jie veikia skirtingai, tod\u0117l mokslininkai mano, kad lekanemabas tur\u0117s daug didesn\u012f poveik\u012f kei\u010diant Alzheimerio ligos eig\u0105. Adukanumabas s\u0105veikauja su jau sugrupuotais amiloido baltymais. Tuo tarpu lekanemabas \u012fsiki\u0161a anks\u010diau, veikdamas \"protofibriles\", t. y. filamentus, kurie ilgainiui taps plok\u0161tel\u0117mis.<\/p>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" loading=\"lazy\" width=\"1024\" height=\"558\" src=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog2-1024x558.jpg\" alt=\"\" class=\"wp-image-27500\" srcset=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog2-1024x558.jpg 1024w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog2-300x163.jpg 300w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog2-768x419.jpg 768w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog2-18x10.jpg 18w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog2-100x54.jpg 100w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/new-treatment-for-alzheimer-blog2.jpg 1123w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\"><em>Iliustracijas galima rasti <strong><a href=\"https:\/\/mindthegraph.com\/app\/illustrations\" target=\"_blank\" rel=\"noreferrer noopener\">Mind the Graph<\/a><\/strong><\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2><a href=\"https:\/\/www.alzheimersresearchuk.org\/wp-content\/uploads\/2022\/12\/how-lecanemab-works.jpg\"><\/a>Ar yra koki\u0173 nors \u0161alutini\u0173 poveiki\u0173?<\/h2>\n\n\n\n<p>Pana\u0161u, kad lekanemabo nepageidaujamas poveikis iki \u0161iol buvo ma\u017eesnis nei adukanumabo. Tyrim\u0105 atlikusi bendrov\u0117 \"Eisai\" teig\u0117, kad 12,6% pacient\u0173 patyr\u0117 ARIA-E smegen\u0173 u\u017edegim\u0105, kuris gali b\u016bti mirtinas, ta\u010diau yra i\u0161gydomas, jei vaisto vartojimas nutraukiamas arba suma\u017einama jo doz\u0117.&nbsp;<\/p>\n\n\n\n<p>Kita vertus, ma\u017edaug tre\u010ddaliui adukanumab\u0105 vartojusi\u0173 pacient\u0173 ARIA-E i\u0161sivyst\u0117 per vis\u0105 gydymo laikotarp\u012f. <a href=\"https:\/\/www.beingpatient.com\/aduhelm-side-effects-fda-monitoring\/\">vaisto 3 faz\u0117s tyrimo.&nbsp;<\/a><\/p>\n\n\n\n<p>Lecanemabo eksperimento metu mir\u0117 13 pacient\u0173, kurie beveik tolygiai pasiskirst\u0117 gydymo ir placebo grup\u0117se: septyni mir\u0117 gydymo grup\u0117je ir \u0161e\u0161i - placebo grup\u0117je.&nbsp;<\/p>\n\n\n\n<p>Prie\u0161 i\u0161leisdama vaist\u0105 \u012f rink\u0105, FDA per\u017ei\u016br\u0117s visus eksperimento metu \u012fvykusius \u012fvykius, \u012fskaitant 13 mirties atvej\u0173. Ta\u010diau kol kas vaistas atrodo daug \u017eadantis.<\/p>\n\n\n\n<h2>Paverskite savo duomenis lengvai suprantamais<\/h2>\n\n\n\n<p>Pagal <a href=\"https:\/\/www.kantar.com\/inspiration\/research-services\/why-visuals-influence-survey-respondent-engagement-pf\">tyrimas,<\/a> \u017emogaus smegenys sukurtos vaizdams apdoroti ir gali tai daryti mil\u017eini\u0161ku grei\u010diu. Vaizdus galima \u012fsisavinti bent du kartus grei\u010diau nei tekst\u0105. Taigi pasinaudokite \u0161ia informacija ir pasirinkite toki\u0105 priemon\u0119, kaip \"Mind The Graph\", kad lengvai sukurtum\u0117te esteti\u0161kai patraukli\u0105 med\u017eiag\u0105 savo darbui, kuri didelius teksto kiekius gali paversti \u012fsp\u016bdingais ir lengvai matomais vaizdiniais.<\/p>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mind the Graph patirtis | Grafin\u0117s santraukos k\u016brimas\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/GwLYcX1uo1s?feature=oembed&#038;enablejsapi=1&#038;origin=https:\/\/mindthegraph.com\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"is-layout-flex wp-block-buttons\">\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link has-background wp-element-button\" href=\"https:\/\/mindthegraph.com\/\" style=\"border-radius:50px;background-color:#dc1866\" target=\"_blank\" rel=\"noreferrer noopener\">Iliustracijomis pagausinkite mano tyrimus<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:44px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Atraskite lekanemab\u0105 - daug \u017eadant\u012f nauj\u0105 vaist\u0105 Alzheimerio ligai gydyti. Su\u017einokite apie jo veikimo mechanizm\u0105, naud\u0105 ir galim\u0105 poveik\u012f.<\/p>","protected":false},"author":28,"featured_media":27504,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[959,28],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>What Is Lecanemab, the New Treatment for Alzheimer&#039;s?<\/title>\n<meta name=\"description\" content=\"Discover Lecanemab, the promising new drug for Alzheimer&#039;s treatment. Learn about its mechanism, benefits, and potential impact.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mindthegraph.com\/blog\/lt\/naujas-gydyba-alzheimeriui-gydyti\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What Is Lecanemab, the New Treatment for Alzheimer&#039;s?\" \/>\n<meta property=\"og:description\" content=\"Discover Lecanemab, the promising new drug for Alzheimer&#039;s treatment. Learn about its mechanism, benefits, and potential impact.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mindthegraph.com\/blog\/lt\/naujas-gydyba-alzheimeriui-gydyti\/\" \/>\n<meta property=\"og:site_name\" content=\"Mind the Graph Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-10T18:17:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-25T11:31:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/blog.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1124\" \/>\n\t<meta property=\"og:image:height\" content=\"613\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jessica Abbadia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"What Is Lecanemab, the New Treatment for Alzheimer&#039;s?\" \/>\n<meta name=\"twitter:description\" content=\"Discover Lecanemab, the promising new drug for Alzheimer&#039;s treatment. Learn about its mechanism, benefits, and potential impact.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/blog.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jessica Abbadia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What Is Lecanemab, the New Treatment for Alzheimer's?","description":"Discover Lecanemab, the promising new drug for Alzheimer's treatment. Learn about its mechanism, benefits, and potential impact.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mindthegraph.com\/blog\/lt\/naujas-gydyba-alzheimeriui-gydyti\/","og_locale":"lt_LT","og_type":"article","og_title":"What Is Lecanemab, the New Treatment for Alzheimer's?","og_description":"Discover Lecanemab, the promising new drug for Alzheimer's treatment. Learn about its mechanism, benefits, and potential impact.","og_url":"https:\/\/mindthegraph.com\/blog\/lt\/naujas-gydyba-alzheimeriui-gydyti\/","og_site_name":"Mind the Graph Blog","article_published_time":"2023-04-10T18:17:16+00:00","article_modified_time":"2023-04-25T11:31:20+00:00","og_image":[{"width":1124,"height":613,"url":"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/blog.jpg","type":"image\/jpeg"}],"author":"Jessica Abbadia","twitter_card":"summary_large_image","twitter_title":"What Is Lecanemab, the New Treatment for Alzheimer's?","twitter_description":"Discover Lecanemab, the promising new drug for Alzheimer's treatment. Learn about its mechanism, benefits, and potential impact.","twitter_image":"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2023\/04\/blog.jpg","twitter_misc":{"Written by":"Jessica Abbadia","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mindthegraph.com\/blog\/new-treatment-for-alzheimers\/","url":"https:\/\/mindthegraph.com\/blog\/new-treatment-for-alzheimers\/","name":"What Is Lecanemab, the New Treatment for Alzheimer's?","isPartOf":{"@id":"https:\/\/mindthegraph.com\/blog\/#website"},"datePublished":"2023-04-10T18:17:16+00:00","dateModified":"2023-04-25T11:31:20+00:00","author":{"@id":"https:\/\/mindthegraph.com\/blog\/#\/schema\/person\/96ecc2d785106e951f7773dc7c96d699"},"description":"Discover Lecanemab, the promising new drug for Alzheimer's treatment. Learn about its mechanism, benefits, and potential impact.","breadcrumb":{"@id":"https:\/\/mindthegraph.com\/blog\/new-treatment-for-alzheimers\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mindthegraph.com\/blog\/new-treatment-for-alzheimers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mindthegraph.com\/blog\/new-treatment-for-alzheimers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mindthegraph.com\/blog\/"},{"@type":"ListItem","position":2,"name":"What Is Lecanemab, the New Treatment for Alzheimer&#8217;s?"}]},{"@type":"WebSite","@id":"https:\/\/mindthegraph.com\/blog\/#website","url":"https:\/\/mindthegraph.com\/blog\/","name":"Mind the Graph Blog","description":"Your science can be beautiful!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mindthegraph.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"lt-LT"},{"@type":"Person","@id":"https:\/\/mindthegraph.com\/blog\/#\/schema\/person\/96ecc2d785106e951f7773dc7c96d699","name":"Jessica Abbadia","image":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/mindthegraph.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f477bd20199beb376b04b2fda9a2cec5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f477bd20199beb376b04b2fda9a2cec5?s=96&d=mm&r=g","caption":"Jessica Abbadia"},"description":"Jessica Abbadia is a lawyer that has been working in Digital Marketing since 2020, improving organic performance for apps and websites in various regions through ASO and SEO. Currently developing scientific and intellectual knowledge for the community's benefit. Jessica is an animal rights activist who enjoys reading and drinking strong coffee.","sameAs":["https:\/\/www.linkedin.com\/in\/jessica-abbadia-9b834a13b\/"],"url":"https:\/\/mindthegraph.com\/blog\/lt\/author\/jessica\/"}]}},"_links":{"self":[{"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/posts\/26453"}],"collection":[{"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/comments?post=26453"}],"version-history":[{"count":5,"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/posts\/26453\/revisions"}],"predecessor-version":[{"id":27512,"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/posts\/26453\/revisions\/27512"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/media\/27504"}],"wp:attachment":[{"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/media?parent=26453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/categories?post=26453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/lt\/wp-json\/wp\/v2\/tags?post=26453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}